高级搜索
电化学治疗联合化疗泵植入治疗肝转移癌的临床研究[J]. 肿瘤防治研究, 2003, 30(01): 53-54. DOI: 10.3971/j.issn.1000-8578.85
引用本文: 电化学治疗联合化疗泵植入治疗肝转移癌的临床研究[J]. 肿瘤防治研究, 2003, 30(01): 53-54. DOI: 10.3971/j.issn.1000-8578.85
A clinical analysis of metastatic liver carcinoma treated with electrochemical therapy(ECT) and chemotherapy portal vein through pump[J]. Cancer Research on Prevention and Treatment, 2003, 30(01): 53-54. DOI: 10.3971/j.issn.1000-8578.85
Citation: A clinical analysis of metastatic liver carcinoma treated with electrochemical therapy(ECT) and chemotherapy portal vein through pump[J]. Cancer Research on Prevention and Treatment, 2003, 30(01): 53-54. DOI: 10.3971/j.issn.1000-8578.85

电化学治疗联合化疗泵植入治疗肝转移癌的临床研究

A clinical analysis of metastatic liver carcinoma treated with electrochemical therapy(ECT) and chemotherapy portal vein through pump

  • 摘要: 目的 电化学治疗 (ECT)联合门静脉系局部区域化疗治疗肝转移癌的疗效评估。方法  4 0例肝转移癌患者随机分成两组, A组门静脉系植入化疗泵化疗配合ECT治疗, B组单纯门静脉系植入化疗泵化疗。结果 A组 7例患者完全缓解 (CR), 7例部分缓解 (PR), 有效率 (CR +PR) 70 %。B组CR患者 0例, PR患者 5例, 有效率 2 5 %。两组CEA、CA199指标及血清免疫球蛋白效价的变化有明显差异。结论 ECT联合门静脉系区域化疗治疗肝转移癌, 提高了缓解率和近期生存率。

     

    Abstract: Objective Therapeutic efficiency was evaluated for electrochemical therapy and chemotherapy portal vein through pump in metastatic liver carcinoma. Methods 40 patients with mestastatic liver carcinoma and unresectable will be separate to A and B group. A group were treated by ECT and chemotherapy portal vein through pump. B group were treated only by chemotherapy portal vein through pump. Results 7 cases obtained completed remission(CR) and 7 cases obtained partial remission(PR) in A group. The total resp...

     

/

返回文章
返回